Literature DB >> 27485347

Influence of the Time of Intravenous Administration of Paracetamol on its Pharmacokinetics and Ocular Disposition in Rabbits.

Agnieszka Karbownik1, Agnieszka Bienert1, Włodzimierz Płotek2, Tomasz Grabowski3, Magdalena Cerbin-Koczorowska4, Anna Wolc5,6, Edmund Grześkowiak1.   

Abstract

BACKGROUND AND OBJECTIVES: Paracetamol is one of the most common analgesics and antipyretics applied in health care. The aim of the study was to investigate the influence of the time-of-day administration on the paracetamol pharmacokinetics and its penetration into aqueous humour (AH).
METHODS: Rabbits were divided into three groups: I-receiving paracetamol at 08.00 h, II-receiving paracetamol at 16.00 h, and III-receiving paracetamol at 24.00 h. Paracetamol was administered intravenously at a single dose of 35 mg/kg. The concentrations of paracetamol and its metabolite (paracetamol glucuronide) in the plasma, as well as in AH were measured with the validated HPLC-UV method.
RESULTS: No significant differences in the pharmacokinetic parameters of paracetamol was observed. When the drug was administered at 24.00 h,  elimination half-life (t 1/2kel) of paracetamol glucuronide was longer than when the drug was administered 08.00 h (P = 0.0193). In addition, a statistically significant increase in the paracetamol glucuronide/paracetamol ratio was observed when the drug was administered at 08.00 vs. 16.00 h (P ≤ 0.0001) and 24.00 h (P ≤ 0.0001).
CONCLUSIONS: There was no chronobiological effect on the pharmacokinetic parameters of paracetamol.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27485347     DOI: 10.1007/s13318-016-0365-y

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  35 in total

1.  Comparison of drug permeabilities across the blood-retinal barrier, blood-aqueous humor barrier, and blood-brain barrier.

Authors:  Ryotaro Toda; Kouichi Kawazu; Masanobu Oyabu; Tatsuya Miyazaki; Yoshiaki Kiuchi
Journal:  J Pharm Sci       Date:  2011-06-02       Impact factor: 3.534

2.  Temporal variations in paracetamol absorption and metabolism in man.

Authors:  F Kamali; J R Fry; G D Bell
Journal:  Xenobiotica       Date:  1987-05       Impact factor: 1.908

3.  Onset of acetaminophen analgesia: comparison of oral and intravenous routes after third molar surgery.

Authors:  P L Moller; S Sindet-Pedersen; C T Petersen; G I Juhl; A Dillenschneider; L A Skoglund
Journal:  Br J Anaesth       Date:  2005-03-24       Impact factor: 9.166

4.  Chronopharmacokinetics of paracetamol in normal subjects.

Authors:  J Malan; J Moncrieff; E Bosch
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

5.  Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.

Authors:  Abdul E Mutlib; Theunis C Goosen; Jonathan N Bauman; J Andrew Williams; Shaila Kulkarni; Seva Kostrubsky
Journal:  Chem Res Toxicol       Date:  2006-05       Impact factor: 3.739

6.  Intravenous acetaminophen (paracetamol): comparable analgesic efficacy, but better local safety than its prodrug, propacetamol, for postoperative pain after third molar surgery.

Authors:  Philip Lange Moller; Gitte Irene Juhl; Catherine Payen-Champenois; Lasse Ansgar Skoglund
Journal:  Anesth Analg       Date:  2005-07       Impact factor: 5.108

7.  Time-dependent variations in the organ extraction ratios of acetaminophen in rat.

Authors:  P M Bélanger; M Lalande; F Doré; G Labrecque
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

8.  Ocular disposition of acetaminophen and its metabolites following intravenous administration in rabbits.

Authors:  L Romanelli; P Valeri; L A Morrone; G Pimpinella
Journal:  J Ocul Pharmacol       Date:  1991

9.  Chronopharmacokinetics of acetaminophen in healthy human volunteers.

Authors:  J A Kolawole; P D Chuhwak; S O Okeniyi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jul-Sep       Impact factor: 2.441

10.  Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide.

Authors:  J J Harding; R van Heyningen
Journal:  Br J Ophthalmol       Date:  1988-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.